ALKBH5 and urinary bladder carcinoma: ALKBH5 reduced CKα expression in an m6A-dependent manner, which significantly inhibited glucose uptake and lactate production by bladder cancer cells, and reduced intracellular ATP levels, increasing the sensitivity of bladder cancer to chemotherapy [39].